Adenocarcinoma pancreas
RecruitingSafety Study of VCN-01 with nab‑Paclitaxel and Gemcitabine in Newly Diagnosed Metastatic Pancreatic Cancer Patients
Safety Study of VCN-01 with nab‑Paclitaxel and Gemcitabine in Newly Diagnosed Metastatic Pancreatic Cancer Patients
- Disease:Adenocarcinoma pancreas
- Substances:Genetically modified human adenovirus encoding human PH20 hyaluronidase
Spain- Participants:18–64 years · 65+ years
- Substances:Genetically modified human adenovirus encoding human PH20 hyaluronidase
